정맥 조명기 시장 규모, 점유율 및 동향 분석 보고서 : 기술별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Vein Illuminator Market Summary

The global vein illuminator market size was estimated at USD 157.90 million in 2025 and is expected to reach USD 238.54 million in 2033, growing at a CAGR of 5.24% from 2026 to 2033. The growth is attributed to the rising burden of chronic diseases and obesity, the rising prevalence of venous leg ulcers, and increasing aesthetic & vein treatment procedures.

Moreover, technological advancements in vein imaging are expected to drive the growth. The growing burden of chronic diseases such as diabetes, cancer, along with obesity, is a significant driver of the vein finder and illuminator industry growth, as these conditions directly affect venous access complexity. Patients with diabetes often experience vascular changes such as reduced vein elasticity, microvascular damage, and increased vein fragility. These changes complicate routine venipuncture and intravenous access. For instance, according to the International Diabetes Federation (IDF), approximately 589 million people are currently living with diabetes, with an estimated number to reach 853 million by 2050.

The rising volume of aesthetic and vein treatment procedures further drives the vein illuminator market. The growing demand for minimally invasive cosmetic treatments, such as sclerotherapy, laser vein ablation, and cosmetic injectable procedures, has heightened the need for precise vein visualization. For instance, in 2024, more than 38 million cosmetic surgery procedures were performed worldwide. Similarly, according to the 2024 Procedural Statistics report by the American Society of Plastic Surgeons, around 29% of patients in the U.S. aged 30-39 underwent minimally invasive skin treatments such as lasers, skin resurfacing, and sclerotherapy, which treats varicose and spider veins. In addition, the 2024 Global Survey on Aesthetic/Cosmetic Procedures showed a 42.5% increase in cosmetic procedures over the last four years, with 20.5 million non-surgical procedures and 17.4 million surgical procedures performed in 2024.

Global Vein Illuminator Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global vein illuminator market report based on technology, application, end use, and region:

• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Near-Infrared (NIR)/Infrared Technology
• Transillumination Technology
• Ultrasound-Based Vein Visualization
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• IV Access & Venipuncture
• Blood Collection & Donation
• Sclerotherapy & Vein Treatment
• Surgical, Emergency & Critical Care
• Pediatric, Geriatric & Difficult Access Cases
• Other Application (Medical training & education, etc.)
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Clinics & Diagnostic Centers
• Ambulatory Surgical Centers (ASCs)
• Blood Banks & Donation Centers
• Other (Academic & Research Institutes, etc.)
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Switzerland
  • Turkey
  • Denmark
  • Sweden
  • Norway
  • Poland
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Indonesia
  • Taiwan
  • Hong Kong
  • Philippines
  • Malaysia
• Latin America
  • Brazil
  • Argentina
  • Colombia
  • Chile
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Technology
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing incidence of infant respiratory conditions
    • 3.2.1.2. Rising parental awareness and focus on infant health/hygiene
    • 3.2.1.3. Technological advancements and product innovation
  • 3.2.2. Market Challenge Analysis
    • 3.2.2.1. Safety concerns and improper usage
    • 3.2.2.2. Availability of alternative remedies
• 3.3. Market Entry Strategies
• 3.4. Reimbursement Framework
• 3.5. Vein Illuminator Market Analysis Tools
  • 3.5.1. Porter's Five Forces Analysis
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTLE Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Economic and Social landscape
    • 3.5.2.3. Technological landscape
    • 3.5.2.4. Environmental landscape
    • 3.5.2.5. Legal Landscape

Chapter 4. Vein Illuminator Market: Technology Estimates & Trend Analysis

• 4.1. Technology Segment Dashboard
• 4.2. Technology Market Share Movement Analysis, 2025 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 4.4. Near-Infrared (NIR)/Infrared Technology
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Transillumination Technology
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Ultrasound-Based Vein Visualization
  • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Vein Illuminator Market: Application Estimates & Trend Analysis

• 5.1. Application Dashboard
• 5.2. Application Market Share Movement Analysis, 2025 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. IV Access & Venipuncture
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Blood Collection & Donation
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Sclerotherapy & Vein Treatment
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Surgical, Emergency & Critical Care
  • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Pediatric, Geriatric & Difficult Access Cases
  • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Other Application (Medical training & education, etc.)
  • 5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Vein Illuminator Market: End Use Estimates & Trend Analysis

• 6.1. End Use Segment Dashboard
• 6.2. End Use Market Share Movement Analysis, 2025 & 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Clinics & Diagnostic Centers
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Ambulatory Surgical Centers (ASCs)
  • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Blood Banks & Donation Centers
  • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Other (Academic & Research Institutes, etc.)
  • 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Vein Illuminator Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Dashboard
• 7.2. Regional Market: Key Takeaways
• 7.3. North America
  • 7.3.1. North America Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. North America Vein illuminator market SWOT analysis
  • 7.3.3. U.S.
    • 7.3.3.1. Key country dynamic
    • 7.3.3.2. Regulatory framework
    • 7.3.3.3. Competitive insights
    • 7.3.3.4. U.S. Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Canada
    • 7.3.4.1. Key country dynamic
    • 7.3.4.2. Regulatory framework
    • 7.3.4.3. Competitive insights
    • 7.3.4.4. Canada Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.5. Mexico
    • 7.3.5.1. Key country dynamic
    • 7.3.5.2. Regulatory framework
    • 7.3.5.3. Competitive insights
    • 7.3.5.4. Mexico Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. Europe Vein illuminator market SWOT analysis
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamic
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive insights
    • 7.4.3.4. Germany Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. UK
    • 7.4.4.1. Key country dynamic
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive insights
    • 7.4.4.4. UK Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. France
    • 7.4.5.1. Key country dynamic
    • 7.4.5.2. Regulatory framework
    • 7.4.5.3. Competitive insights
    • 7.4.5.4. France Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Italy
    • 7.4.6.1. Key country dynamic
    • 7.4.6.2. Regulatory framework
    • 7.4.6.3. Competitive insights
    • 7.4.6.4. Italy Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Spain
    • 7.4.7.1. Key country dynamic
    • 7.4.7.2. Regulatory framework
    • 7.4.7.3. Competitive insights
    • 7.4.7.4. Spain Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Netherlands
    • 7.4.8.1. Key country dynamic
    • 7.4.8.2. Regulatory framework
    • 7.4.8.3. Competitive insights
    • 7.4.8.4. Netherlands Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.9. Russia
    • 7.4.9.1. Key country dynamic
    • 7.4.9.2. Regulatory framework
    • 7.4.9.3. Competitive insights
    • 7.4.9.4. Russia Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.10. Switzerland
    • 7.4.10.1. Key country dynamic
    • 7.4.10.2. Regulatory framework
    • 7.4.10.3. Competitive insights
    • 7.4.10.4. Switzerland Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.11. Turkey
    • 7.4.11.1. Key country dynamic
    • 7.4.11.2. Regulatory framework
    • 7.4.11.3. Competitive insights
    • 7.4.11.4. Turkey Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.12. Denmark
    • 7.4.12.1. Key country dynamic
    • 7.4.12.2. Regulatory framework
    • 7.4.12.3. Competitive insights
    • 7.4.12.4. Denmark Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.13. Sweden
    • 7.4.13.1. Key country dynamic
    • 7.4.13.2. Regulatory framework
    • 7.4.13.3. Competitive insights
    • 7.4.13.4. Sweden Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.14. Norway
    • 7.4.14.1. Key country dynamic
    • 7.4.14.2. Regulatory framework
    • 7.4.14.3. Competitive insights
    • 7.4.14.4. Norway Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.15. Poland
    • 7.4.15.1. Key country dynamic
    • 7.4.15.2. Regulatory framework
    • 7.4.15.3. Competitive insights
    • 7.4.15.4. Poland Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. Asia Pacific Vein illuminator market SWOT analysis
  • 7.5.3. Japan
    • 7.5.3.1. Key country dynamic
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive insights
    • 7.5.3.4. Japan Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. China
    • 7.5.4.1. Key country dynamic
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive insights
    • 7.5.4.4. China Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. India
    • 7.5.5.1. Key country dynamic
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive insights
    • 7.5.5.4. India Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. South Korea
    • 7.5.6.1. Key country dynamic
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive insights
    • 7.5.6.4. South Korea Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Australia
    • 7.5.7.1. Key country dynamic
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive insights
    • 7.5.7.4. Australia Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.8. Thailand
    • 7.5.8.1. Key country dynamic
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Competitive insights
    • 7.5.8.4. Thailand Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.9. Indonesia
    • 7.5.9.1. Key country dynamic
    • 7.5.9.2. Regulatory framework
    • 7.5.9.3. Competitive insights
    • 7.5.9.4. Indonesia Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.10. Taiwan
    • 7.5.10.1. Key country dynamic
    • 7.5.10.2. Regulatory framework
    • 7.5.10.3. Competitive insights
    • 7.5.10.4. Taiwan Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.11. Hong Kong
    • 7.5.11.1. Key country dynamic
    • 7.5.11.2. Regulatory framework
    • 7.5.11.3. Competitive insights
    • 7.5.11.4. Hong Kong Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.12. Philippines
    • 7.5.12.1. Key country dynamic
    • 7.5.12.2. Regulatory framework
    • 7.5.12.3. Competitive insights
    • 7.5.12.4. Philippines Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.13. Malaysia
    • 7.5.13.1. Key country dynamic
    • 7.5.13.2. Regulatory framework
    • 7.5.13.3. Competitive insights
    • 7.5.13.4. Malaysia Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Vein Illuminator Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Latin America SWOT analysis
  • 7.6.4. Brazil
    • 7.6.4.1. Key country dynamic
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive insights
    • 7.6.4.4. Brazil Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. Argentina
    • 7.6.5.1. Key country dynamic
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive insights
    • 7.6.5.4. Argentina Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. Colombia
    • 7.6.6.1. Key country dynamic
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive insights
    • 7.6.6.4. Colombia Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.7. Chile
    • 7.6.7.1. Key country dynamic
    • 7.6.7.2. Regulatory framework
    • 7.6.7.3. Competitive insights
    • 7.6.7.4. Chile Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. MEA Vein illuminator market SWOT analysis
  • 7.7.3. South Africa
    • 7.7.3.1. Key country dynamic
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive insights
    • 7.7.3.4. South Africa Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. Saudi Arabia
    • 7.7.4.1. Key country dynamic
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive insights
    • 7.7.4.4. Saudi Arabia Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. UAE
    • 7.7.5.1. Key country dynamic
    • 7.7.5.2. Regulatory framework
    • 7.7.5.3. Competitive insights
    • 7.7.5.4. UAE Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.6. Kuwait
    • 7.7.6.1. Key country dynamic
    • 7.7.6.2. Regulatory framework
    • 7.7.6.3. Competitive insights
    • 7.7.6.4. Kuwait Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.7. Qatar
    • 7.7.7.1. Key country dynamic
    • 7.7.7.2. Regulatory framework
    • 7.7.7.3. Competitive insights
    • 7.7.7.4. Qatar Vein illuminator market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis, 2025
• 8.3. Company Categorization
• 8.4. Company Profiles/Listing
  • 8.4.1. Christie Medical Holdings, Inc. (Acquired by CAREstream Group in June 2019)
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Hellovein
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Veinlite
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. AccuVein, Inc.
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Venoscope
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. ZD Medical Inc.
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Koninklijke Philips N.V.
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Infinium Medical, Inc.
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Vivolight
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. VINO Optics
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. GE Healthcare
    • 8.4.11.1. Overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Product benchmarking
    • 8.4.11.4. Strategic initiatives